David McNair
GlaxoSmithKline (United Kingdom)(GB)
Publications by Year
Research Areas
RNA and protein synthesis mechanisms, Antimicrobial Resistance in Staphylococcus, Antimicrobial Peptides and Activities, Microbial Natural Products and Biosynthesis, Lipoproteins and Cardiovascular Health
Most-Cited Works
- → Optimisation of aryl substitution leading to potent methionyl tRNA synthetase inhibitors with excellent gram-Positive antibacterial activity(2003)37 cited
- → ATP-Citrate Lyase as a Target for Hypolipidemic Intervention. Design and Synthesis of 2-Substituted Butanedioic Acids as Novel, Potent Inhibitors of the Enzyme(1996)33 cited
- → ATP-Citrate Lyase as a Target for Hypolipidemic Intervention. 2. Synthesis and Evaluation of (3R*,5S*)-ω-Substituted-3-carboxy-3,5-dihydroxyalkanoic Acids and Their γ-Lactone Prodrugs as Inhibitors of the Enzyme in Vitro and in Vivo(1998)30 cited
- → Conformational restriction of methionyl tRNA synthetase inhibitors leading to analogues with potent inhibition and excellent gram-Positive antibacterial activity(2003)25 cited
- → Synthesis and Activity of Analogues of SB-219383. Novel Potent Inhibitors of Bacterial Tyrosyl tRNA Synthetase.(2000)22 cited
- → ATP-citrate-lyase as a target for hypolipidemic intervention. Sulfoximine and 3-hydroxy-.beta.-lactam containing analogs of citric acid as potential tight-binding inhibitors(1992)22 cited
- → Potent synthetic inhibitors of tyrosyl tRNA synthetase derived from C-pyranosyl analogues of SB-219383(2001)21 cited
- → 9-(Sulfoximinoalkyl)guanine nucleosides as potential antiherpetic agents(1993)11 cited
- Growth and development during germination of the pea seed(1966)
- → ChemInform Abstract: 9‐(Sulfoximinoalkyl)guanine Nucleosides as Potential Antiherpetic Agents.(1993)